Since nuclear factor-κB (NF-κB) activation mediated by the TLR4 agonist amplified the magnitude of STING activation, this NDDS synergizing with aPD-1 induced tumor regression and established systemic antitumor memory 190. The gene discussed is STING1; the disease is neoplasm.